Immunosuppressive Drugs Companies

ID: MRFR/Pharma/6756-HCR

111 Pages

Vikita Thakur

Last Updated: February 16, 2025

Immunosuppressive drugs are medications that suppress the activity of the immune system. These drugs are commonly used in organ transplantation to prevent the body from rejecting a transplanted organ. They are also prescribed for certain autoimmune disorders where the immune system mistakenly attacks the body's own tissues.

Immunosuppressive Drugs Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)8.33%

2024 Market Size$ 5.65 Billion

2025 Market Size$ 6.19 Billion

2035 Market Size$ 13.68 Billion

Key Players

Roche

Novartis

Bristol-Myers Squibb

AbbVie

Merck & Co.

Amgen

Trends

Rise in Autoimmune Disorders
Advancements in Biotechnology
Growing Patient Awareness

Opportunities

Market Growth Projections
Growing Awareness and Education
Advancements in Drug Development

Summary Table of Contents Segmentation Methodology Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Immunosuppressive Drugs Market

Latest Immunosuppressive Drugs Companies Update:

Pfizer (US) announces positive phase 3 trial results for its investigational IL-23 inhibitor etrasimod for the treatment of moderate-to-severe ulcerative colitis.

Roche (Switzerland) receives FDA approval for Actemra (tocilizumab) for the treatment of macrophage activation syndrome (MAS) in children and adults.

Bristol Myers Squibb (US) and Takeda Pharmaceutical Company Limited (Japan) collaborate to develop and commercialize a novel anti-CD40 monoclonal antibody for the treatment of autoimmune diseases.

Novartis (Switzerland) acquires Gyroscope Therapeutics Inc. (US) for USD 800 million, gaining access to GT004, a potential best-in-class IL-17A inhibitor for various autoimmune diseases.

Sanofi (France) expands its portfolio of immunosuppressive drugs with the acquisition of Amun Therapeutics Inc. (US), gaining access to a pipeline of novel immune-tolerizing therapies.

List of Immunosuppressive Drugs Key companies in the market

Accord Healthcare (UK)
Astella Pharma (Japan)
Bristol-Myers Squibb Company (US)
Genzyme Co. (Switzerland)
Hoffmann-La Roche AG (US
GlaxoSmithKline PLC (UK)
Glenmark Pharmaceuticals, Inc. (India)
Mylan Laboratories Inc. (US)
Pfizer Inc. (US)
Novartis AG (Switzerland)
Actavis, Inc.

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”